A Phase 1, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of APX001, to Investigate the Effect of Food on APX001 and to Investigate the Drug-Drug Interaction Potential of APX001
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs APX 001 (Primary) ; APX 001 (Primary)
- Indications Mycoses
- Focus Adverse reactions
- Sponsors Amplyx Pharmaceuticals
- 31 Jul 2017 Status changed from active, no longer recruiting to completed.
- 30 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Nov 2016 New trial record